ERP Planning for Pre-Commercial Biotech Companies
The biotechnology sector is expanding, both in terms of the number and size of businesses in the market, and, most importantly, in the range of positive health outcomes it delivers. Global market size was estimated at over $1000 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 13.9% from 2022 to 2030.
Pre-commercial biotech is a core element of the industry. As companies in this sector expand, they need systems solutions that can both run and support their business processes today and scale seamlessly as the business grows. Life sciences in general, and pre-commercial biotech in particular, has attributes and requirements that are unique to the sector, making it even more critical that enterprises choose a systems platform that is right for their specific needs.
In the pre-commercial biotech space, companies must be able to deliver high-quality, error-free outcomes. At Crescense, we understand that imperative, and we leverage our industry expertise to help biotech companies meet their specific needs. At the same time, we are also flexible to adapt to the resource and financial constraints that those biotech companies often face. So, what do our experts have to say about ERP planning for pre-commercial biotech companies?
In this eBook, we outline why SAP is the best fit for pre-commercial biotech companies, the drivers and challenges behind choosing an ERP solution (including budgeting for SAP), and where to start when implementing SAP.